{"id":"NCT01345253","sponsor":"GlaxoSmithKline","briefTitle":"GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia","officialTitle":"GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05-23","primaryCompletion":"2015-09-15","completion":"2018-09-21","firstPosted":"2011-05-02","resultsPosted":"2016-12-02","lastUpdate":"2019-10-04"},"enrollment":709,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus"],"interventions":[{"type":"DRUG","name":"Belimumab","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Belimumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of belimumab in addition to standard therapy compared to placebo in subjects in Northeast Asia with systemic lupus erythematosus (SLE) over a 52 week period.","primaryOutcome":{"measure":"Percent of Participants Achieving Systemic Lupus Erythematosus (SLE) Responder Index (SRI) Response Rate at Week 52 for Double-blind Phase.","timeFrame":"Week 52","effectByArm":[{"arm":"Placebo","deltaMin":40.1,"sd":null},{"arm":"Belimumab 10 mg/kg","deltaMin":53.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":47,"countries":["China","Japan","South Korea"]},"refs":{"pmids":["29295825","39115551","38216728","38140854","37228028","35428697","34741731","34628605","34531304","33687069"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":43,"n":235},"commonTop":["Upper respiratory tract infection","Viral upper respiratory tract infection","Nasopharyngitis","Pyrexia","Cough"]}}